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Research into brain-gut interactions, and the use of brain
imaging, as potential investigative tools for functional
gastrointestinal disorders, such as irritable bowel
syndrome, is a promising new area. Studies are beginning
to identify the structure and function of regions of the brain
and their relationships to pain perception, stress, and other
psychosocial variables. These imaging modalities may also
have diagnostic potential, and perhaps even therapeutic
applications, particularly with regard to understanding the
benefit of centrally targeted modalities such as
antidepressants and psychological treatments.
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T
he field of gastroenterology is moving
beyond its traditional anatomical bound-
aries. New cross disciplinary studies, such
as basic and translational research, epidemiol-
ogical, cost, and decision analyses, and genetics
are expanding our knowledge of the gastro-
intestinal disorders, and are creating new
opportunities for clinical and health service
applications. A particularly promising new devel-
opment is research into brain-gut interactions,
and the use of brain imaging, including positron
emission tomography (PET) and functional
magnetic resonance imaging (fMRI), as potential
investigative tools for functional gastrointestinal
disorders (FGIDs).1 Such studies are beginning
to identify the structure and function of regions
of the brain and their relationships to pain
perception, stress, and other psychosocial vari-
ables. These imaging modalities may also have
diagnostic potential, and perhaps even therapeu-
tic applications, particularly with regard to
understanding the benefit of centrally targeted
modalities such as antidepressants and psycho-
logical treatments.
In this issue of Gut, Morgan and colleagues2
make an original effort to integrate our evolving
knowledge of central pain modulatory centres,
stress influences on central nervous system
(CNS) function, and the effects of antidepressant
treatment in patients with irritable bowel syn-
drome (IBS) (see page 601). The results have
important research and clinical implications.
However, like all breakthrough studies, their
findings may raise more questions than answers,
and open the door to future investigations.
To understand the study results and their
implications, it is important to first review our
developing knowledge on brain-gut interactions
as related to pain processing in IBS and the
potential role for brain imaging. There are several
major developments, listed from the most
established to the more speculative areas.
PATIENTS WITH IBS HAVE GREATER GUT
REACTIVITY TO VARIOUS STRESSORS
Greater stress reactivity is a hallmark of the
disorder, and it is manifested as increased
motility and visceral sensitivity to a variety of
stimuli, including meals, visceral distension,
physical activity, hormonal changes, and psy-
chological stress.3 4 For example, IBS patients
compared with control subjects rate rectal dis-
tension stimuli significantly higher in intensity
and unpleasantness when given physical (for
example, cold water immersion) or psychological
(dichotomous listening) stress,5 and this is
associated with higher emotional reactivity in
terms of feeling more stress, anger, and anxiety
than control subjects.6
INCREASED VISCERAL SENSITIVITY IS
NOT SUFFICIENT TO EXPLAIN PAIN
REPORTS OF IBS
The emerging evidence is that central processes,
mediated by psychosocial distress, contribute to
pain perception, at least as much or more than
visceral signals.7 Patients with more severe IBS
are distinguished from those with milder IBS by
having greater psychological distress and dis-
turbances yet with no differences in visceral
sensation thresholds.8 Thus while chronic stress
affects reports of pain perception, it does not
appear to affect sensory thresholds. In fact, FGID
patients with a history of sexual or physical
abuse report greater pain9 but have higher visceral
sensation thresholds.10 These data highlight the
importance of central pain processing in ampli-
fying the perception of visceral signals.
Abbreviations: FGIDs, functional gastrointestinal
disorders; IBS, irritable bowel syndrome; PI-IBS, post
infectious IBS; PET, positron emission tomography; fMRI,
functional magnetic resonance imaging; CNS, central
nervous system; ACC, anterior cingulate cortex; pACC,
anterior perigenual ACC; MCC, mid cingulate cortex;
aMCC, anterior midcingulate cortex of the ACC; ACC-
CD, cognitive division of the ACC
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STRESS IS A PERMISSIVE FACTOR IN THE
DEVELOPMENT OF CERTAIN FUNCTIONAL
GASTROINTESTINAL DISORDERS
This is best demonstrated with post infectious IBS (PI-IBS)
where the persistence of functional gastrointestinal symp-
toms for several months after a bacterial infection is
associated not only with increased inflammation in the gut
mucosa but also with increased psychological distress present
at the time of the initial infection.11 12 In fact, these
associations were present even when the abnormal motility
and visceral hypersensitivity were similar between PI-IBS
patients and those who became asymptomatic after the
infection.11 Thus it was the CNS amplification of these
peripheral signals in the psychologically distressed group that
raised them to conscious awareness, thereby perpetuating the
symptoms.13
THE CNS IS ‘‘WIRED’’ TO MODULATE VISCERAL
AFFERENT PAINFUL SIGNALS AND RESPONSES TO
STRESS
The ‘‘gate control’’ pain system allows for bidirectional
signals between the gut and brain. It begins with visceral
signals ascending to the CNS via the dorsal horn of the spinal
cord, through the thalamus, and then laterally to the
somatosensory cortex and medially to the insula, medial
thalamus, amygdala, and cingulate cortex. Amplification of
these signals can occur at the level of the mucosa via
sensitisation from inflammation or injury, at the dorsal horn
(central sensitisation), or higher at midbrain structures. In
addition, corticofugal pathways from the emotional motor
system via the periaqueductal gray and nucleus raphe
magnus descend to the dorsal horn where they can amplify
or suppress afferent signals from the gut.14 15 Furthermore,
these descending pain systems in addition to neuroendocrine
(for example, hypothalamic-pituitary-adrenal axis), cogni-
tive-attentional, and autonomic control loci are closely
integrated, and mediate and affect stress responses.16 This
occurs to a greater degree in patients with IBS who show
increased motor, sensory, and autonomic reactivity via these
central modulatory systems.16
SPECIFIC AREAS OF THE CORTICOLIMBIC
MODULATORY SYSTEM REGULATE VISCERAL PAIN
AND EMOTIONAL RESPONSES
Although our understanding of the areas of regional brain
activation is only in its infancy, there is some consensus that
while there are similar areas of cortical activation, visceral
signals tend to activate regions associated with unpleasant
affect and autonomic responses while somatic signals
activate regions associated with skeletomotor responses and
spatial orientation.17 18 Specifically, visceral stimulation acti-
vates corticolimbic modulatory systems, including the insular
cortex, thalamus and hypothalalamus, right ventrolateral
prefrontal cortex, amygdala, and anterior cingulate cortex
(ACC).
‘‘The anterior cingulate cortex (ACC) is the region of
particular interest with regard to pain regulation, stress
response, and the FGIDs’’
Relevant to this discussion is the cingulate cortex which
consists of several structurally and functionally heteroge-
neous regions, as shown in fig 1.19 20 For the purpose of this
discussion, the ACC is the region of particular interest with
regard to pain regulation, stress response, and the FGIDs.
This area processes information on stimulus intensity,
emotion, mood, and attention, and is also the area involved
with unpleasant affect and autonomic responses. It consists
of two subregions: (1) an anterior perigenual ACC (pACC),
also called the rostral ACC (rACC) and (2) a more dorsal and
caudal portion located in the middle of the cingulate gyrus,
the mid cingulate cortex (MCC).
The anterior region of the MCC (shown in green in fig 1) is
a subregion called the anterior midcingulate cortex of the
ACC (aMCC); it has a variety of other names including the
caudal ACC, dorsal ACC, or cognitive division of the ACC
Figure 1 Structure of the cingulate cortex. The anterior region of the mid cingulate cortex (MCC, shown in green) is a subregion called the anterior
mid cingulate cortex of the ACC (aMCC); it has a variety of other names including the caudal ACC, the dorsal ACC (dACC), or cognitive division of the
ACC (ACC-CD). pACC, anterior perigenual ACC; rACC, rostral ACC.
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(ACC-CD). The pACC is linked and sensitively activates with
emotions such as happiness and sadness, or in response to
anticipation and anxiety. It is involved in many overlapping
networks and may be activated or deactivated with pain.
Possibly activation of the pACC could result from receiving
increasing noxious information or may reflect efforts to try to
modulate or decrease such information. It also has connec-
tions to the amygdala and may suppress its activity during
fear/painful states.21 It contains endogenous opioids such as
diprenorphine22 and has high concentrations of opioid
receptors23 which in some way links it to pain regulation.
The more caudal or dorsal aMCC is associated with
attentional processes, decision making (response selection),
and pre-motor activities in response to visceral events that
require a recoding of behaviour.20 Recent data also suggest
that activation of this aMCC with visceral pain is associated
with high levels of fear.20 Thus with painful visceral
stimulation, there may be an increase in activity of the
pACC associated with emotional distress and an increase in
activity of the aMCC (ACC-CD) where pain is coupled with
fear and with increased attention to the stimulus and
inhibition of motor activity (response selection).15
FUNCTIONAL BRAIN IMAGING CAN
DEMONSTRATE DIFFERENCES IN CENTRAL PAIN
MODULATORY SYSTEMS BETWEEN PATIENTS WITH
IBS AND CONTROLS
PET and fMRI, the most commonly used techniques in
FGIDs, provide a window to increases (activation) or
decreases (deactivation) in brain function based, respectively,
on regional blood flow or degree of oxygenation. With IBS,
this is usually done with rectal distension to provide a painful
afferent signal that registers a response in the brain which is
measured numerically or visually using three dimensional
coordinates and t scores to show the degree of activation. The
measurements are done with whole brain analyses or are
targeted to specific anatomical regions of interest. Usually,
the baseline value is subtracted from the stimulated value to
give a level of activation (or deactivation), and with
comparative analyses the activation level of the control group
may be subtracted or contrasted with the target group.
‘‘PET and fMRI, the most commonly used techniques in
FGIDs, provide a window to increases (activation) or
decreases (deactivation) in brain function based, respec-
tively, on regional blood flow or degree of oxygenation’’
With regard to IBS, several published studies indicate
differences in levels of activation between patients with IBS
and normal controls of these corticolimbic pain modulatory
systems. Despite inconsistencies across the studies, in general
there is an association of ACC activation to rectal distension
in IBS relative to controls.1 Studies using both fMRI and PET
show increases in activity of unspecified areas of the ACC
compared with controls24 while others show increased
activity of the aMCC18 25–28 or pACC29 compared with controls,
thus linking emotion or fear with visceral pain in these
patients, and others show increased pACC activity in controls
relative to IBS.30 31 Some of these studies also show an
expected correlation between ACC activation and greater pain
reports to rectal distension.24 26 31 32
Unfortunately, the field of brain imaging in FGIDs is not
yet developed enough to provide more specific information or
to clarify the reported differences in regional brain activation
in the FGIDs and their relationship to stress, pain, and
emotion. The studies are confounded and methodologically
limited because:
(a) activations often involve neural circuitry of several
interacting regions16 33 34 (which for simplicity are not
discussed) which make it difficult to target single sites,
(b) there may be imaging differences between PET and
fMRI,
(c) sex differences exist,35
(d) there are confounding effects on the registration of
images to rectal distension with anticipation of that
event,36
(e) there may be confounding central influences, such as
placebo effects,33
(f) there is clinical heterogeneity among patients with
regard to diagnosis and severity of the disorders, and
(g) there are methodological issues in technique, lack of
instrument and protocol standardisation, low ‘‘signal to
noise’’ ratios, and limitations in measuring functionally
heterogeneous regions of the cingulate and other brain
regions.
‘‘Differences between IBS and controls do exist and
topographical mapping of the regions of activation is an
area for future study in IBS’’
Thus it is difficult to obtain a consensus across studies on
which brain subregions show increased or decreased activity.1
Nevertheless, differences between IBS and controls do exist
and topographical mapping of the regions of activation is an
area for future study in IBS.
THE BRAIN AREAS OF INTEREST IN IBS ARE ALSO
AREAS LINKED TO AND ACTIVATED BY STRESS
Parallel research involving brain imaging within psychiatry
relates activation of the ACC and related limbic structures to
psychosocial disturbances, including post traumatic stress
disorder,37 social rejection,34 and many studies relating to
anxiety, depression, and cognitive functioning,38 including
the recall of emotional experiences.39 With regard to FGIDs,
preliminary data show that in IBS, ACC activation to rectal
distension correlates with anxiety,40 stressful life events,
maladaptive coping,32 and a history of abuse.30 Furthermore,
abuse history and IBS diagnosis appear to have synergistic
effects causing even greater activation of the pACC.29 These
studies begin to support clinical observations of the connec-
tions between psychological distress, IBS, and greater pain
reporting.9
BRAIN IMAGING MAY HELP EXPLAIN THE
MECHANISMS FOR, AND PERMIT TARGETING OF,
SUSCEPTIBLE GROUPS TO CENTRALLY TARGETED
TREATMENTS IN IBS
Studies in IBS have begun to show the efficacy of
antidepressants,41 42 cognitive behavioural therapy,41 43 hyp-
nosis,44 and other psychological interventions.4 Given their
putative actions with regard to central analgesia, stress
reduction, and improvement in psychological symptoms, the
use of brain imaging may help us understand their
mechanisms of action and possibly monitor and predict their
effects. With regard to IBS, one case report showed that
clinical improvement associated with antidepressants and
counselling occurred with a reduction in symptom reports,
visceral pain threshold, and aMCC activity,26 and a study of
cognitive behavioural treatment showed that when compared
with pretreatment values, IBS patients had significant
reductions in symptom severity, anxiety, and pACC activity.45
Within psychiatry, brain imaging is now being studied to
predict which patients are more likely to respond to
antidepressant and other psychotropic treatments, as
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psychiatric improvement is associated with metabolic
changes in the brain that can be registered through these
imaging techniques.46 47
‘‘Brain imaging is now being studied to predict which
patients are more likely to respond to antidepressant and
other psychotropic treatments, as psychiatric improvement
is associated with metabolic changes in the brain that can
be registered through these imaging techniques’’
Given this background, the results of the study of Morgan
and colleagues2 in this issue of Gut can be put into clearer
perspective. The authors set out to determine whether
treatment with a low dose of amitriptyline (not sufficient
to treat major depression) in female IBS patients compared
with patients not receiving treatment would be associated
with changes in ACC activation in response to rectal
distension and psychological stress. They found that rectal
pain induced significant activation of the pACC, right insula,
and right prefrontal cortex, and treatment led to reduced pain
related activations of the pACC and left posterior parietal
cortex, but only during stress. The conclusion is notable:
there is stress related inhibition of brain activation of pACC
(along with other areas) in the treated group. This is logical
as the pACC is part of the corticolimbic network that
modulates the affective and cognitive components of pain
perception and is activated in stress. Thus amitriptyline may
uncouple the negative effects of stress on pain via the ACC.
The findings are potentially important but far from
conclusive due to several methodological limitations, in part
related to the infancy of this area of research. Firstly, there
was no healthy control group to determine whether these are
generalised effects or are more specific to IBS. Secondly, the
study may have been underpowered and this may explain
only trends in terms of reductions in pain responses to rectal
distension in the treated group or in the reduction of aMCC
(called ‘‘ACC-cognitive’’ in this study) activation, and the
lack of correlation of brain activity with anxiety or depres-
sion, all of which might be anticipated to have occurred. Thus
this study is difficult to interpret with regard to the clinical
relevance of the noted brain activation changes, or whether
the effects relate to pain reduction pathways, stress effects, or
both. Thirdly, it is unclear the degree to which the treatment
effects on depression or other psychological symptoms might
confound the brain activation results; although a low dose of
amitriptyline was chosen to obviate this possibility, psycho-
logical scores were not evaluated for possible interaction
effects in this study. Fourthly, we do not know the
generalisability of the effects on other clinical populations,
including males, or patients with more or less severe
symptoms or differing stool patterns. For examples, sex
differences in brain activation has been reported,35 and there
may be differences in brain responses between milder
patients and more severe patients with high degrees of
psychosocial morbidity, Fifthly, given the possibility of
anticipation and placebo effects, and their independent
influences on brain activation, it would be necessary to
replicate this study by a parallel design with baseline
assessment and to also consider a non-drug control group.
Finally, it is beyond our current methodology to evaluate the
complex relationships between the relevant regions of
interest in the pain neuromatrix33 and also to determine
whether the treatment effects are primarily central, peri-
pheral, or both.48
‘‘In the end, it is likely that we may develop more effective
treatments for our patients with FGIDs and also truly
understand how these treatments are working’’
Nevertheless, the study is creative, novel, and at the
forefront of investigation in this field. The authors have taken
a large step to initiate what will hopefully be a series of
investigations to link augmentation of pain and symptom
reporting to stress, and responses to centrally active treat-
ments via their central mechanistic associations in IBS. For
the future it is likely that the best yield for such studies will
occur by identifying specific subgroups amenable to more
targeted investigations and then conducting focused assess-
ments. This will involve more precise characterisation of
patients and their symptom features, standardisation of
physiological and psychological methods, and the use of
profiles characterised by specific psychophysiological and
biological features.1 In the end, it is likely that we may
develop more effective treatments for our patients with
FGIDs and also truly understand how these treatments are
working.
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